Kevin Kyle, Germfree’s CEO, shares the first look at Germfree and AST’s revolutionary collaboration, unveiling a cutting-edge isolator that is set to redefine standards in the pharmaceutical industry. This co-development represents a watershed moment, as the two industry giants pool their expertise to develop the very first end-to-end American-designed, sourced, and manufactured turn-key aseptic fill-finish processing solution.

If you’d like to learn more about our partnership with AST, click here.